Takayuki Yamaguchi Selected Research

Takayuki Yamaguchi Research Topics

Disease

5	Arthritis (Polyarthritis) 01/2023 - 05/2012
5	Neoplasms (Cancer) 11/2022 - 11/2007
4	Rheumatoid Arthritis 01/2023 - 05/2012
3	Inflammation (Inflammations) 01/2020 - 11/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2018 - 05/2017
3	Staphylococcal Scalded Skin Syndrome (Ritter's Disease) 10/2005 - 05/2002
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2021 - 01/2018
2	Experimental Arthritis 01/2020 - 01/2020
2	Infections 01/2019 - 01/2018
2	Venous Thromboembolism 06/2015 - 01/2011
2	Blister (Bulla) 11/2005 - 05/2002
2	Impetigo (Impetigo Contagiosa) 04/2005 - 05/2002
1	Hyperalgesia 01/2023
1	Pain (Aches) 01/2023
1	Stomach Neoplasms (Stomach Cancer) 11/2022
1	Fever (Fevers) 10/2022
1	Neutropenia 12/2021
1	Acute Cholecystitis 02/2021
1	Tuberculosis (Tuberculoses) 01/2019
1	Fatigue 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Osteoarthritis 06/2015
1	Type 2 Diabetes Mellitus (MODY) 12/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Schizophrenia (Dementia Praecox) 04/2008
1	Psychotic Disorders (Schizoaffective Disorder) 04/2008
1	Colonic Neoplasms (Colon Cancer) 11/2007
1	Carcinogenesis 11/2007
1	Skin Diseases (Skin Disease) 10/2005

Drug/Important Bio-Agent (IBA)

4	ExfoliatinsIBA 11/2005 - 05/2002
3	JTE-952IBA 01/2023 - 01/2020
3	trametinibIBA 12/2012 - 07/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2020
2	Macrophage Colony-Stimulating FactorIBA 01/2023 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 05/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021 - 01/2018
2	CytokinesIBA 12/2021 - 09/2016
2	Interleukin-17 (Interleukin 17)IBA 11/2018 - 06/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2012 - 04/2011
2	Desmoglein 1IBA 11/2005 - 05/2002
1	Therapeutic UsesIBA 01/2023
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	Oxygen (Dioxygen)IBA 10/2022
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	LigandsIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	VaccinesIBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2018
1	Guanosine Diphosphate (GDP)IBA 01/2018
1	RetinoidsIBA 06/2017
1	GlucocorticoidsIBA 05/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	Ointments (Pastes)IBA 09/2016
1	InterleukinsIBA 09/2016
1	InterferonsIBA 09/2016
1	Betamethasone (Celestone)FDA Link 09/2016
1	Interleukin-22 (IL-22)IBA 09/2016
1	SteroidsIBA 09/2016
1	Imiquimod (Aldara)FDA LinkGeneric 09/2016
1	Messenger RNA (mRNA)IBA 09/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	edoxabanIBA 01/2016
1	delgocitinibIBA 11/2015
1	Janus Kinase InhibitorsIBA 11/2015
1	Janus KinasesIBA 11/2015
1	NAD (NADH)IBA 12/2012
1	Collagen Type II (Type II Collagen)IBA 05/2012
1	Leflunomide (Arava)FDA LinkGeneric 05/2012
1	Mitogen-Activated Protein KinasesIBA 05/2012
1	Indicators and Reagents (Reagents)IBA 05/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2012
1	Immunoglobulin G (IgG)IBA 01/2011
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2011
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	AntibodiesIBA 01/2011
1	Antipsychotic Agents (Antipsychotics)IBA 04/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2007
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2007
1	N- (3- (5- (4- bromo- 2- fluorophenylamino)- 3- cyclopropyl- 8- methyl- 2,4,7- trioxo- 3,4,7,8- tetrahydro- 2H- pyrido(2,3- d)pyrimidin- 1- yl)phenyl)methanesulfonamideIBA 11/2007
1	pyrimidineIBA 11/2007
1	DesmogleinsIBA 10/2005
1	Neutralizing AntibodiesIBA 04/2005
1	Desmoglein 3IBA 05/2002
1	Cadherins (E-Cadherin)IBA 05/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2011
3	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2016 - 01/2011
1	Adjuvant Chemotherapy 11/2022
1	Gastrectomy 11/2022
1	Laparoscopic Cholecystectomy 02/2021
1	Subcutaneous Injections 11/2015
1	Oral Administration 07/2011
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2011